Coquí Radiopharmaceuticals Completes Schematic Design of $330 million Medical Isotope Production Facility

Completed schematics marks another step towards becoming first U.S. commercial producer of Molybdenum-99.

Download the full press release >

Coquí Radiopharmaceuticals Inks Deal with INVAP

Coquí Pharma has formally signed a contract with INVAP to design its Medical Isotope Production Facility in Alachua, Fla.

Download the full press release >

Coquí Radiopharmaceuticals Appoints Ian Turner to Board of Directors

Coquí Pharma announces that Ian Turner, the former head of the radiopharmaceuticals business for the Australian Nuclear Science and Technology Organization (ANSTO), has been appointed to its board of directors.

Download the full press release >

Coquí Announces Approximate Cost of Medical Isotope Production Facility at NNSA’s 2014 Mo-99 Conference

At a DOE sponsored medical isotope topical meeting in Washington, D.C., Coquí RadioPharmaceuticals Corp. (Coquí Pharma) announced that it would cost approximately $250 million to bring online a new medical isotope production facility in the United States.

Download the full press release >

Coquí to Build Medical Isotope Production Facility with Proven Technology

Among the collection of aspiring medical isotope production companies looking to build facilities in the U.S., Coquí RadioPharmaceuticals Corp. (Coquí) stands out as the only one using a design and production method already proven in the commercial markets.

Download the full press release >